CMU researchers have published in Science a new 3D bioprinting method that brings the field of tissue engineering one step closer to being able to 3D print a full-sized, adult human heart.
A team of researchers from Carnegie Mellon University has published a paper in Science that details a new technique allowing anyone to 3D bioprint tissue scaffolds out of collagen, the major structural protein in the human body. This first-of-its-kind method brings the field of tissue engineering one step closer to being able to 3D print a full-sized, adult human heart.
The technique, known as Freeform Reversible Embedding of Suspended Hydrogels (FRESH), has allowed the researchers to overcome many challenges associated with existing 3D bioprinting methods, and to achieve unprecedented resolution and fidelity using soft and living materials.
Each of the organs in the human body, such as the heart, is built from specialized cells that are held together by a biological scaffold called the extracellular matrix (ECM). This network of ECM proteins provides the structure and biochemical signals that cells need to carry out their normal function. However, until now it has not been possible to rebuild this complex ECM architecture using traditional biofabrication methods.
What we’ve shown is that we can print pieces of the heart out of cells and collagen into parts that truly function, like a heart valve or a small beating ventricle.
Adam Feinberg, Professor, Biomedical Engineering and Materials Science & Engineering
“What we’ve shown is that we can print pieces of the heart out of cells and collagen into parts that truly function, like a heart valve or a small beating ventricle,” says Adam Feinberg, a professor of biomedical engineering (BME) and materials science & engineering, whose lab performed this work. “By using MRI data of a human heart, we were able to accurately reproduce patient-specific anatomical structure and 3D bioprint collagen and human heart cells.”
Over 4,000 patients in the United States are waiting for a heart transplant, while millions of others worldwide need hearts but are ineligible for the waitlist. The need for replacement organs is immense, and new approaches are needed to engineer artificial organs that are capable of repairing, supplementing, or replacing long-term organ function. Feinberg, who is a member of Carnegie Mellon’s Bioengineered Organs Initiative and the Next Manufacturing Center, is working to solve these challenges with a new generation of bioengineered organs that more closely replicate natural organ structures.
“Collagen is an extremely desirable biomaterial to 3D print with because it makes up literally every single tissue in your body,” explains Andrew Hudson, a BME Ph.D. student in Feinberg’s lab and co-first author on the paper. “What makes it so hard to 3D print, however, is that it starts out as a fluid—so if you try to print this in air it just forms a puddle on your build platform. So we’ve developed a technique that prevents it from deforming.”
The FRESH 3D bioprinting method developed in Feinberg’s lab allows collagen to be deposited layer-by-layer within a support bath of gel, giving the collagen a chance to solidify in place before it is removed from the support bath. With FRESH, the support gel can be easily melted away by heating the gel from room temperature to body temperature after the print is complete. This way, the researchers can remove the support gel without damaging the printed structure made of collagen or cells.
This method is truly exciting for the field of 3D bioprinting because it allows collagen scaffolds to be printed at the large scale of human organs. And it is not limited to collagen, as a wide range of other soft gels including fibrin, alginate, and hyaluronic acid can be 3D bioprinted using the FRESH technique, providing a robust and adaptable tissue engineering platform. Importantly, the researchers also developed open-source designs so that nearly anyone, from medical labs to high school science classes, can build and have access to low-cost, high-performance 3D bioprinters.
Looking forward, FRESH has applications in many aspects of regenerative medicine, from wound repair to organ bioengineering, but it is just one piece of a growing biofabrication field. “Really what we’re talking about is the convergence of technologies,” says Feinberg. “Not just what my lab does in bioprinting, but also from other labs and small companies in the areas of stem cell science, machine learning, and computer simulation, as well as new 3D bioprinting hardware and software.”
“It is important to understand that there are many years of research yet to be done,” adds Feinberg, “but there should still be excitement that we’re making real progress towards engineering functional human tissues and organs, and this paper is one step along that path.”
Learn more: 3D printing the human heart
The Latest on: 3D bioprinting
via Google News
The Latest on: 3D bioprinting
- 3D Bioprinting Market Size, Share, Competition Landscape, Manufacturers Analysis and Future Opportunity Outlook 2030 | Says FMI Analyston April 9, 2021 at 11:49 am
Apr 09, 2021 (MARKITWIRED via COMTEX) -- A recent market study published by Future Market Insights (FMI) on the 3D bioprinting market offers global industry analysis for 2015-2019 & opportunity ...
- Seaweed molecules found to aid wound healingon April 9, 2021 at 7:30 am
so the use of 3D bioprinting to create scaffolds for wound healing has attracted much attention," Professor Wallace said. "Here we have formulated a bioink for 3D bioprinting, containing ulvan and ...
- Researchers Devise Rapid 3D Printing Method for Human Organson April 7, 2021 at 6:22 am
Use of hydrogels in novel stereolithography process eyed for fabricating viable tissues for transplants and other biomedical applications.
- 3D-printed organs could save lives by addressing the transplant shortageon April 7, 2021 at 5:15 am
Due to the global organ shortage and limited organ donors, thousands of patients are left wanting organs and tissues in cases of severe injuries, illness or genetic conditions. Many of these patients ...
- 3D Bioprinting Market Share, Demand, Industry Analysis, Growth, Applications, Types and Forecasts Report 2027on April 6, 2021 at 4:28 pm
The MarketWatch News Department was not involved in the creation of this content. Apr 06, 2021 (AB Digital via COMTEX) -- The global 3D Bioprinting Market is expected to reach USD 2,687.8 million by ...
- How growth of the 3D Cell Culture Market will unfold over the next decadeon April 6, 2021 at 6:14 am
and tissue engineering with the help of 3D bioprinting. The 3D cell culture market is growing due to the introduction of novel therapeutics, and through the release of generic biopharmaceuticals or ...
- 3D Bioprinting Market Analysis by Industry Size, Share, Revenue Growth, Development and Demand Forecast to 2025on April 5, 2021 at 12:36 pm
The Global 3D Bioprinting Market (henceforth referred to as the market studied) was valued at USD 586.13 million in 2019 and is expected to reach USD 1949.94 million by 2025, registering a CAGR of ...
- 3D-Bioprinted Cell Therapy and Disease Modeling Applicationson April 2, 2021 at 4:09 am
Besides contributing to precision medicine directly, they also contribute through 3D bioprinting. In 3D bioprinting, molecular genetics and cell biology are teamed with engineering and robotics to ...
- 3D bio-printing technique to benefit diabetes patients for bone repair: Studyon March 30, 2021 at 1:10 am
Bone defect is a serious problem for people with diabetes after fractures, but a new technique involving 3D bioprinting of a 'scaffold' for bone repair offers for the first time a way to overcome ...
- Diabetes patients to benefit from new 3D bio-printingon March 29, 2021 at 7:32 pm
Bone defect is a serious problem for people with diabetes after fractures but a new technique involving 3D bioprinting of a caffold for bone repair offers f ...
via Bing News